Volunteers for human trials of Spain’s Hipra Covid vaccine ready to be selected

VOLUNTEERS who applied to take part in human trials of the new Spanish Hipra Covid vaccine will start to be chosen on August 30

On August 11, the Spanish Agency for Medicines and Health Products (AEMPS) authorised the first clinical trials to take place in humans, of a new Spanish Covid-19 vaccine, the PHH-1V vaccine from Hipra, a laboratory that has its plant in the Girona municipality of Amer.

Hospitals reportedly received dozens of calls and emails from people interested in taking part in the human trials, and the selection of the most suitable volunteers to participate in the clinical trial will now begin, after concluding with remarkable success the admission of volunteers this week.

August 30 is the date that the screening of volunteers for participation in the human trials will begin, in the Josep Trueta hospitals in Girona and the Clinic de Barcelona, where, in this first phase of testing, a total of 30 suitable people aged between 18 and 39, who have never contracted the virus, or been vaccinated, will be chosen out of all the applicants, and then, in the subsequent weeks, they will be injected with doses of the new vaccine and monitored.

It is a phase I / IIa trial of dose escalation, randomised, controlled and masked – the Hipra vaccine or an authorised vaccine will be administered in a masked form, so as to prevent its identification by both the patient and the research team – which will then study the safety and tolerability of this vaccine, as well as its immunogenicity and efficacy as secondary objectives, as reported by elperiodico.com.

___________________________________________________________

Thank you for reading, and don’t forget to check The Euro Weekly News for all your up-to-date local and international news stories.